Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Prevalence, Mortality, and Healthcare Utilization in Hemophagocytic Lymphohistiocytosis Among Lymphoma Patients: Insights From the NIS Database

ABCL - 1385

Prevalence, Mortality, and Healthcare Utilization in Hemophagocytic Lymphohistiocytosis Among Lymphoma Patients: Insights From the NIS Database

Srijani Thannir

Poster Presenter: Srijani Thannir

Thumbnail for Global Disparities in Access to CAR-T Therapy for Hematologic Malignancies: Emerging Challenges in Equitable Cellular Therapy Delivery

CT - 1387

Global Disparities in Access to CAR-T Therapy for Hematologic Malignancies: Emerging Challenges in Equitable Cellular Therapy Delivery

Vaishnavi Vallurupalli

Poster Presenter: Vaishnavi Vallurupalli

Previous 1...111 112 113 114 115 116 117...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Secondary Primary Malignancies Associated With CD20ΧCD3 Bispecific T-Cell Engaging Antibodies in Patients With B-Cell Non-Hodgkin's Lymphoma

ABCL - 1388

Secondary Primary Malignancies Associated With CD20ΧCD3 Bispecific T-Cell Engaging Antibodies in Patients With B-Cell Non-Hodgkin's Lymphoma

Carmel Awadallah

Poster Presenter: Carmel Awadallah

Thumbnail for Optimal Hemoglobin Thresholds in Hematologic Malignancies: Comparative Evidence for Restrictive and Liberal Transfusion

CT - 1389

Optimal Hemoglobin Thresholds in Hematologic Malignancies: Comparative Evidence for Restrictive and Liberal Transfusion

Hem Prajapati

Poster Presenter: Hem Prajapati

Thumbnail for Addition of Fixed Low-Dose Nivolumab to R-DA-EPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PMBCL)

ABCL - 1390

Addition of Fixed Low-Dose Nivolumab to R-DA-EPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PMBCL)

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Thumbnail for Automated Extraction of Adverse Events Reveals Relationship Between HMA/Ven Cycle Duration and Symptom Burden

AML - 1393

Automated Extraction of Adverse Events Reveals Relationship Between HMA/Ven Cycle Duration and Symptom Burden

John Lazar

Poster Presenter: John Lazar

Thumbnail for Optimizing Donor Age for Allogeneic Transplant in Acute Lymphoblastic Leukemia in the Era of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Prophylaxis

ALL - 1394

Optimizing Donor Age for Allogeneic Transplant in Acute Lymphoblastic Leukemia in the Era of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Prophylaxis

John Behman

Poster Presenter: John Behman

$Thumbnail for Salvage Chemotherapy Intensity Does Not Impact Survival in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Retrospective Analysis$

AML - 1395

Salvage Chemotherapy Intensity Does Not Impact Survival in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Noah Balestra

Poster Presenter: Noah Balestra

$Thumbnail for Real-World Infection Risk Associated With Teclistamab in Relapsed/Refractory Multiple Myeloma$

MM - 1396

Real-World Infection Risk Associated With Teclistamab in Relapsed/Refractory Multiple Myeloma

Nour Sabiha Naji

Poster Presenter: Nour Sabiha Naji

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors